OstomyCure continues clinical trial to fully evaluate its TIES implant
We are delighted to announce that our clinical trial for our TIES implant has now been initiated at hospitals in the UK, Sweden, Poland, Austria and India.
Archives
Read more 
Latest update on The TIES Solution
In today’s Europe of stricter safety and regulatory protocols, we are committed to do whatever it takes to bring the lifestyle changing TIES solution to as many people as possible”.
Professor David Jayne joins the OstomyCure clinical trial
We are pleased to announce that Professor David Jayne and his team at Leeds Teaching Hospital NHS Trust in the UK have joined our clinical trial to evaluate our TIES® implant.
Read more
New Stockholm office
OstomyCure has moved its Stockholm operations from Kista to the Karolinska Campus area in Solna in the heart of the bustling Stockholm life science scene.
Read more
First Patients enrolled in the C03 clinical study in the UK
Today, the first patient was enrolled in the TIES03 study of the Ostom Cure Transcuteous Implant Evacuation System (TIES®). A 64-year-old female from the UK had the TIES port successfully implanted in a procedure that took less than an hour with no complications. “We see the TIES® Solution as a potential step change for ileostomy patients, providing them with a better quality of life,” said Prof. David Jayne,
Read more
OstomyCure AS receives sought-after Horizon 2020 EU grant of € 2.5 Mio.
OstomyCure AS has received a EU grant of € 2.5 Mio. via the Horizon 2020 Project.(https://ec.europa.eu/programmes/horizon2020/what-horizon-2020). “This EU grant is a major milestone for OstomyCure AS, and further confirms the very unique benefits of TIES Solution which are now endorsed by a very capable public institution” – Says Dr. Ben Broennimann, CEO of OstomyCure AS
Read more
Photostream
© 2022 OstomyCure. All rights reserved | Web by RIIoT Digital